CHO-Based Assay Kit

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology, March 2023
Volume 47
Issue 3
Pages: 12

Charles River’s HCP-ELISA kit is designed to increase the efficiency and efficacy of HCP assay development.

Charles River’s HCP-ELISA Kit

Charles River’s HCP-ELISA Kit

Charles River Laboratories’ enzyme-linked immunosorbent assay (ELISA) kit is designed for the detection and quantitation of residual host cell proteins (HCP) in Chinese hamster ovary (CHO)-based biotherapeutics. Building on the company’s HCP-GAPex service, the HCP–ELISA kit is designed to increase the efficiency and efficacy of HCP assay development.

The HCP–ELISA kit has a 96-well assay plate and has a time-to-result of approximately three hours. It leverages avian immunoglobulin Y antibodies as the primary detection technology, which are derived from specific-pathogen-free chicken eggs developed exclusively by AVS Bio.

Charles River Laboratories

Download Issue PDF
Articles in this issue
data web
Harnessing Technology to Ensure Drug Safety
Africa Studio/Stock.adobe.com – Variances and means are compared using F and T tests, respectively.
Justification of Using Weight Variation Instead of Content Uniformity for Release of Relevant OSD Forms
Excipients Impact Stability in mRNA-LNP Formulations
Excipients Impact Stability in mRNA-LNP Formulations
Shopping cart with medical ampoule, syringe and capsules on a blue background, copy space, top view. Concept of purchasing medicines, increasing drug prices. Vertical photo | Image Credit: © yaroslav1986 - Stock.adobe.com
Influencing Change in Drug Delivery
Intestine decorative model with pills on light blue background. Probiotics and prebiotics for microbiome intestine, healthy digestion concept. Top view, flat lay, copy space | Image Credit: © Elena - Stock.adobe.com
Frontrunner in Microbiome Therapeutics
Implementing Process Analytical Technology
Implementing Process Analytical Technology
omar/Stock.Adobe.com
Automated Inspection of Pre-filled Syringes and Biologics During Fill/Finish
Paulista/stock.adobe.com – For high-risk analytical procedures, control-chart monitoring of selected performance data can provide early warning of changes in performance.
Ongoing Analytical Procedure Performance Verification—Stage 3 of USP<1220>
Taking Steps Toward Supply Chain Continuity
Taking Steps Toward Supply Chain Continuity
Medicine, Healthcare And Medicine, Vaccination | Image Credit: © BillionPhotos.com - Stock.adobe.com
Keeping Europe’s Medicines Stocked
WEYO - STOCK.ADOBE.COM - The trends shaping the growth of the biologics outsourcing industry demand attention.
The Logistics of Outsourcing Biologics
Vaccine Development Builds on COVID-19 Breakthroughs
Vaccine Development Builds on COVID-19 Breakthroughs
Landkarte *** Europa | Image Credit: © beugdesign - Stock.adobe.com
EMA Guidance on Paediatric Investigation Plans
Outsourcing Still Vital
Outsourcing Still Vital
Retro classic typewriter from circa 1950s with sheet of paper and aged books on wooden desk front aquamarine wall background. Nostalgic writer's work place concept. Vintage old style filtered photo | Image Credit: © BrAt82 - stock.adobe.com
Feeling the Pinch
Recent Videos
Behind the Headlines episode 6
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Related Content
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Abzena Expands Analytical Services with GMP Cell-Based Potency Testing in US and UK

Feliza Mirasol
November 22nd 2024
Article

The company has expanded its early and late phase analytical capabilities by including GMP cell-based potency assays at its sites in Cambridge, UK, and San Diego, Calif.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Circio and Certest to Collaborate on LNP Formulations

Feliza Mirasol
November 21st 2024
Article

The companies will collaborate to create and test circVec DNA–LNP formulations for use in potential therapeutic applications.

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

March 26th 2024
Podcast

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

CDMO SEKISUI Expands its CGMP Biopharma Manufacturing Capacity

Feliza Mirasol
November 20th 2024
Article

SEKISUI has used a £15.7 million (US$20.7 million) investment to expand its clinical-grade drug substance manufacturing at its UK site.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Alentis Therapeutics to Advance Anti-Claudin-1 ADCs to Treat Solid Tumors on $181.4 Million Financing

Feliza Mirasol
November 19th 2024
Article

Financing from OrbiMed, Novo Holdings, Jeito Capital, and others will enable Alentis Therapeutics to advance its pipeline of Claudin-1-targeted ADCs for treating solid tumors.